Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
DH · Nasdaq · United States · Services-Prepackaged Software
In shortDefinitive Healthcare Corp. is loss-making, generates cash and holds more cash than debt, with revenue shrinking (−4.2% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -92.9% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -57.5% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -28.2% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -39.3% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.64× | 70/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.43× | 87/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -19.87× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -3.49 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 15.3% | 81/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 19.9% | 37/100 |
| Operating margin volatility | 108.6% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 2.7% | 32/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
1 older year available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 166 | 223 | 251 | 252 | 242 |
| Cost of revenue | – | 43 | 47 | 55 | 58 |
| Gross profit | 125 | 180 | 204 | 197 | 183 |
| Research & development | 19 | 35 | 42 | 37 | 35 |
| Operating income | (27) | (44) | (330) | (711) | (224) |
| Interest expense | 26 | 11 | 15 | 15 | 11 |
| Pre-tax income | (63) | (42) | (308) | (634) | (209) |
| Income tax | (0.4) | (18) | (19) | (42) | (10) |
| Net income | (18) | (7.2) | (202) | (413) | (139) |
| Diluted EPS | −$0.19 | −$0.07 | −$1.79 | −$3.54 | −$1.30 |
| Diluted shares (millions) | 92 | 101 | 113 | 117 | 107 |
1 older year available with the 10-year history. Essential plan, from €8.25/month →
−3.49 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 10, 2026